ROSOPATAMAB TETRAXETAN
UNII WCY6T25V3A

Substance Identification & Data

This profile provides standardized clinical and technical data for Rosopatamab Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WCY6T25V3A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2260767-50-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WCY6T25V3A
CAS Registry Number
2260767-50-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ROSOPATAMAB TETRAXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174932
National Cancer Institute reference terminology for clinical and research data.
INN ID
11334
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rosopatamab Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROSOPATAMAB TETRAXETAN

Common Names & Synonyms

DOTA-HUJ-591
DOTA-HUJ-591-GS
ROSOPATAMAB TETRAXETAN [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, (ANTI-(HUMAN PROSTATE-SPECIFIC ANTIGEN)) (HUMAN-MUS MUSCULUS MONOCLONAL HUJ591 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HUJ591 .KAPPA.-CHAIN, DIMER, N6-(2-(4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZACYCLODODEC-1-YL)ACETYL)-L-LYSINE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus